RIGL - RIGEL PHARMACEUTICALS INC
28.87
-0.650 -2.251%
Share volume: 354,349
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$29.52
-0.65
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 03-04-2025 | 05-06-2025 | 08-05-2025 | 11-04-2025 | 03-03-2026 | |
| Assets | |||||||||
| Total Assets | 126.519 M | 128.408 M | 139.419 M | 163.976 M | 175.972 M | 206.736 M | 242.534 M | 513.594 M | |
| Current Assets | 92.486 M | 94.723 M | 106.467 M | 135.103 M | 146.563 M | 175.393 M | 214.927 M | 240.166 M | |
| Inventories | 6.579 M | 8.059 M | 4.784 M | 6.002 M | 4.659 M | 10.423 M | 13.303 M | 11.506 M | |
| Other Current Assets | 8.845 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 8.845 M | 13.049 M | 9.422 M | 20.575 M | 31.371 M | 54.972 M | 88.609 M | 114.375 M | |
| Total Receivables | 27.512 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 49.550 M | 36.053 M | 51.692 M | 56.746 M | 45.728 M | 53.407 M | 48.534 M | 40.580 M | |
| Total Non-current Assets | 34.033 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 140.000 K | 115.000 K | 99.000 K | 92.000 K | 76.000 K | 57.000 K | 54.000 K | 0.000 | |
| Other Assets | 4.318 M | 33.570 M | 32.853 M | 28.781 M | 29.333 M | 31.286 M | 27.553 M | 273.428 M | |
| Intangible Assets | 28.863 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 126.519 M | 128.408 M | 139.419 M | 163.976 M | 175.972 M | 206.736 M | 242.534 M | 513.594 M | |
| Total liabilities | 158.190 M | 158.322 M | 154.055 M | 160.688 M | 157.405 M | 124.802 M | 124.925 M | 122.114 M | |
| Total current liabilities | 73.198 M | 58.649 M | 54.312 M | 63.299 M | 66.629 M | 86.636 M | 94.400 M | 99.237 M | |
| Accounts Payable | 9.276 M | 6.130 M | 3.815 M | 3.339 M | 3.954 M | 7.290 M | 3.846 M | 7.191 M | |
| Other liabilities | 39.982 M | 39.981 M | 39.981 M | 44.981 M | 44.981 M | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 14.780 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 44.910 M | 59.692 M | 59.762 M | 52.408 M | 44.931 M | 37.452 M | 29.969 M | 22.482 M | |
| Other liabilities | 39.982 M | 39.981 M | 39.981 M | 44.981 M | 44.981 M | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -31.671 M | -29.914 M | -14.636 M | 3.288 M | 18.567 M | 81.934 M | 117.609 M | 391.480 M | |
| Common stock | 175.203 M | 1.387 B | 1.390 B | 1.393 B | 1.397 B | 1.401 B | 1.409 B | 1.414 B | |
| Retained earnings | -1.416 B | -1.417 B | -1.404 B | -1.390 B | -1.379 B | -1.319 B | -1.291 B | -1.023 B |